drugset / Trial / NCT04170296
Real World CCH Study in Adult Females With Cellulite
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This is a multicenter, open-label, multiple dose, 2 cohort, Phase 3b study to assess the safety and efficacy of CCH in adult women with mild or moderate edematous fibrosclerotic panniculopathy (EFP). Cohort 1 will include approximately 80 subjects with mild or moderate EFP in the posterolateral thighs and Cohort 2 will include approximately 70 subjects with mild or moderate EFP in the buttocks.
Timeline
- Start
- 2019-11-01
- Primary completion
- 2020-10-06
- Completion
- 2021-01-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Collagenase Clostridium Histolyticum | Protein / enzyme biologic | 1.68 mg | — |